DNA gene

Sweet gene victory around the corner? Therapeutic advances come rolling in

As the UK Government opens its new ‘Catapult’ centre devoted to gene therapy manufacturing, could 2018 be the year of its mainstream commercialisation? BV’s...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...

A Synchrotron for Africa: Scientists Unite Behind Proposed Project

With the Zimbabwe dollar now relegated to history, the country’s resilient, albeit battered, economy is once again lubricated by a stable currency. Emerging from...
Farmer with cattle in Cambodia

More investments and surveillance needed to curb misuse of antimicrobials in public health and...

Addressing the Antimicrobial Resistance (AMR) challenge requires a stronger collaborative effort across sectors New York, 21 September 2017 - A stronger global effort, including larger investments...

World Bank Group: Are Stars Aligning for Clean-Energy Financing?

One of the biggest bangs on the opening day of the Paris COP21 climate summit was without doubt the dual announcements by the Breakthrough...

Rosalind Franklin: Uncovering the Double Helix

For scientists, winning a Nobel Prize represents the highest accolade for ground-breaking, original endeavours. Competition for the coveted award can be fierce and skulduggery...

Science-Based Emissions Targets: A New Foundation for Corporate Climate Action

Corporate emissions-reduction targets have become commonplace. In 2014, 80% of companies that reported their emissions to CDP, an international NGO that holds the largest...
Emma Walmsley - CEO of GSK

Emma’s marvellous medicine

GlaxoSmithKline’s mighty empire faces a new chapter with the retirement of Sir Andrew Witty A MOTHER-of-four from the gritty industrial town of Barrow-in-Furness will create...